Safety and Effectiveness of Rivaroxaban and Apixaban compared to warfarin in non-valvular atrial fibrillation patients in the routine clinical practice in the UK (SiERRA UK)

First published 18/02/2019

Last updated 10/07/2024

EU PAS number:

EUPAS28234

Study

Finalised

Documents

Study protocol

Initial protocol

Study 20343_Study protocol_v1.0_2018-11-12_Redacted

English (997.49 KB - PDF)View document

Study results

20343_EU-PASS_Abstract_Redacted

English (425.44 KB - PDF)View document

Study report

SIERRA Study Report SB_27 Sep 2021

English (4.16 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs